LBRX
LB Pharmaceuticals Inc
44.71
-0.23 (-0.51%)
52w low 14.40
50.16 high
84.8% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 21.40M | 14.98M | 22.98M | 250.17M | |
| Current Assets | 21.49M | 45.63M | 28.88M | 308.43M | |
| Net PP&E | 3.00K | 23.00K | 4.16M | 3.73M | |
| Total Assets | 21.49M | 45.66M | 33.53M | 312.93M | |
| Current Liabilities | 469.00K | 2.61M | 8.11M | 7.44M | |
| Total Debt | 24.15M | 0.00 | 3.70M | 3.57M | |
| Total Liabilities | 50.30M | 80.13M | 128.09M | 11.62M | |
| Retained Earnings | -34.95M | -41.22M | -104.32M | -129.53M | |
| Shareholders Equity | -28.81M | -34.47M | -94.55M | 301.31M | |
| Working Capital | 21.02M | 43.03M | 20.77M | 300.99M | |
| Shares Outstanding | 22.44M | 22.44M | 22.44M | 25.30M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--